- Home
- NSPR vs MDAI Comparison
NSPR vs MDAI Comparison
Compare NSPR & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- MDAI
- Stock Information
- Founded
- NSPR 2005
- MDAI 2013
- Country
- NSPR United States
- MDAI United States
- Employees
- NSPR N/A
- MDAI N/A
- Industry
- NSPR Medical/Dental Instruments
- MDAI Medical/Dental Instruments
- Sector
- NSPR Health Care
- MDAI Health Care
- Exchange
- NSPR Nasdaq
- MDAI Nasdaq
- Market Cap
- NSPR 74.8M
- MDAI 69.0M
- IPO Year
- NSPR N/A
- MDAI N/A
- Fundamental
- Price
- NSPR $2.38
- MDAI $2.09
- Analyst Decision
- NSPR Strong Buy
- MDAI Strong Buy
- Analyst Count
- NSPR 2
- MDAI 1
- Target Price
- NSPR $4.50
- MDAI $3.50
- AVG Volume (30 Days)
- NSPR 112.3K
- MDAI 379.5K
- Earning Date
- NSPR 08-05-2025
- MDAI 08-12-2025
- Dividend Yield
- NSPR N/A
- MDAI N/A
- EPS Growth
- NSPR N/A
- MDAI N/A
- EPS
- NSPR N/A
- MDAI N/A
- Revenue
- NSPR $7,066,000.00
- MDAI $27,549,000.00
- Revenue This Year
- NSPR $4.85
- MDAI N/A
- Revenue Next Year
- NSPR $113.47
- MDAI $15.15
- P/E Ratio
- NSPR N/A
- MDAI N/A
- Revenue Growth
- NSPR 7.60
- MDAI 22.27
- 52 Week Low
- NSPR $1.99
- MDAI $0.82
- 52 Week High
- NSPR $3.80
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- NSPR 44.93
- MDAI 39.51
- Support Level
- NSPR $2.35
- MDAI $1.98
- Resistance Level
- NSPR $2.52
- MDAI $2.24
- Average True Range (ATR)
- NSPR 0.14
- MDAI 0.15
- MACD
- NSPR -0.02
- MDAI -0.03
- Stochastic Oscillator
- NSPR 7.50
- MDAI 19.30
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.